APLT Stock Summary and Trading Ideas (Applied Therapeutics | NASDAQ:APLT)

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Applied Therapeutics trades on the NASDAQ stock market under the symbol APLT.

As of January 6, 2025, APLT stock price declined to $0.87 with 5,624,317 million shares trading.

APLT has a beta of 1.36, meaning it tends to be more sensitive to market movements. APLT has a correlation of 0.01 to the broad based SPY ETF.

APLT has a market cap of $101.72 million. This is considered a Micro Cap stock.

In the last 3 years, APLT traded as high as $10.62 and as low as $.50.

The top ETF exchange traded funds that APLT belongs to (by Net Assets): VTI, VXF, IWM, VTWO, IBB.

APLT has underperformed the market in the last year with a return of -61.1%, while the SPY ETF gained +28.7%. In the last 3 month period, APLT fell short of the market, returning -88.6%, while SPY returned +4.2%. However, in the most recent 2 weeks APLT has outperformed the stock market by returning +0.9%, while SPY returned +0.1%.

APLT support price is $.87 and resistance is $1.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APLT shares will trade within this expected range on the day.